CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, is focused on the development, licensing and commercialization of pharmaceutical products through the leveraging of their validated drug delivery technology. The company has U.S. and international patents as well as other proprietary rights to technologies that encourage the absorption of drugs. For further information, visit the Company’s web site at www.cpexpharm.com.
- 17 years ago
QualityStocks
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…